In the last 12 months, insiders at Cue Biopharma, Inc. ($CUE) filed 48 transactions with the SEC: 6 open-market purchases totaling $130,647 and 0 sales totaling $0. Net insider sentiment: net buying.
Cue Biopharma, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Sarraf Pasha (Not found) — 7 transactions totaling $99,747
- PASSERI DANIEL R (CHIEF EXECUTIVE OFFICER) — 3 transactions totaling $30,900
- Broadfoot Jill Marie (Not found) — 2 transactions totaling $0
- Millar Kerri-Ann (CHIEF FINANCIAL OFFICER) — 3 transactions totaling $0
- Garzone Pamela (Not found) — 3 transactions totaling $0
View all SEC Filings for Cue Biopharma, Inc. (CUE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Kiener Peter A | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 100,869,349 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Sarraf Pasha | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 100,869,349 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Verheyen Patrick | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 100,869,349 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Morich Frank | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 100,869,349 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Garzone Pamela | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 100,869,349 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Broadfoot Jill Marie | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 100,869,349 | 9999.99% | 0.02% |
| Dec. 30, 2025 | Sarraf Pasha | Not found | P | Common Stock | 86947 | $0.32 | 168,324.0000 | 100,869,349 | 106.84% | 0.09% |
| Dec. 30, 2025 | Sarraf Pasha | Not found | P | Common Stock | 77417 | $0.30 | 323,857.0000 | 100,869,349 | 31.41% | 0.08% |
| Dec. 30, 2025 | Sarraf Pasha | Not found | P | Common Stock | 78116 | $0.31 | 246,440.0000 | 100,869,349 | 46.41% | 0.08% |
| Dec. 30, 2025 | Sarraf Pasha | Not found | P | Common Stock | 77148 | $0.30 | 81,377.0000 | 100,869,349 | 1824.26% | 0.08% |
| Dec. 30, 2025 | Sarraf Pasha | Not found | P | Common Stock | 4229 | $0.31 | 4,229.0000 | 100,869,349 | 9999.99% | 0.00% |
| Sept. 26, 2025 | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 56,328,348 | 9999.99% | 0.05% |
| Dec. 3, 2025 | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 100,869,349 | 9999.99% | 0.07% |
| Sept. 29, 2025 | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 56,328,348 | 9999.99% | 0.09% |
| Sept. 29, 2025 | Warren Lucinda | CHIEF BUSINESS OFFICER | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 56,328,348 | 9999.99% | 0.22% |
| Sept. 29, 2025 | Azam Usman | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 1875000 | $0.00 | 1,875,000.0000 | 56,328,348 | 9999.99% | 3.33% |
| June 4, 2025 | Broadfoot Jill Marie | Not found | A | Stock Option (right to buy) | 48800 | $0.00 | 48,800.0000 | 56,328,348 | 9999.99% | 0.09% |
| March 21, 2025 | Levisetti Matteo | Chief Medical Officer | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 56,328,348 | 9999.99% | 0.44% |
| March 21, 2025 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 56,328,348 | 9999.99% | 0.36% |
| March 21, 2025 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 56,328,348 | 9999.99% | 0.80% |
| March 21, 2025 | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 56,328,348 | 9999.99% | 0.18% |
| March 21, 2025 | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 56,328,348 | 9999.99% | 0.36% |
| March 21, 2025 | Warren Lucinda | CHIEF BUSINESS OFFICER | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 56,328,348 | 9999.99% | 0.44% |
| March 10, 2025 | Sarraf Pasha | Not found | A | Stock Option (right to buy) | 48800 | $0.00 | 48,800.0000 | 56,328,348 | 9999.99% | 0.09% |
| Jan. 2, 2025 | Verheyen Patrick | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 56,328,348 | 9999.99% | 0.04% |
| Jan. 2, 2025 | Garzone Pamela | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 56,328,348 | 9999.99% | 0.04% |
| Jan. 2, 2025 | Kiener Peter A | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 56,328,348 | 9999.99% | 0.04% |
| Jan. 2, 2025 | Morich Frank | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 56,328,348 | 9999.99% | 0.04% |
| Jan. 2, 2025 | DRISCOLL FREDERICK W | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 56,328,348 | 9999.99% | 0.04% |
| Dec. 16, 2024 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | P | Common Stock | 30000 | $1.03 | 164,578.0000 | 51,229,701 | 22.29% | 0.06% |
| Nov. 25, 2024 | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 51,229,701 | 9999.99% | 0.39% |
| Sept. 3, 2024 | Warren Lucinda | CHIEF BUSINESS OFFICER | A | Stock Option (right to buy) | 350000 | $0.00 | 350,000.0000 | 45,754,794 | 9999.99% | 0.76% |
| June 5, 2024 | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 45,754,794 | 9999.99% | 0.13% |
| June 5, 2024 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 45,754,794 | 9999.99% | 0.13% |
| June 5, 2024 | Fox Michael J | Not found | A | Stock Option (right to buy) | 48800 | $0.00 | 48,800.0000 | 45,754,794 | 9999.99% | 0.11% |
| June 5, 2024 | Suri Anish | PRESIDENT AND CSO | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 45,754,794 | 9999.99% | 0.33% |
| June 5, 2024 | Levisetti Matteo | Chief Medical Officer | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 45,754,794 | 9999.99% | 0.27% |
| March 6, 2024 | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 45,754,794 | 9999.99% | 0.38% |
| March 6, 2024 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 45,754,794 | 9999.99% | 0.87% |
| March 6, 2024 | Suri Anish | PRESIDENT AND CSO | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 45,754,794 | 9999.99% | 0.66% |
| March 6, 2024 | Levisetti Matteo | Chief Medical Officer | A | Stock Option (right to buy) | 260000 | $0.00 | 260,000.0000 | 45,754,794 | 9999.99% | 0.57% |
| March 6, 2024 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 45,754,794 | 9999.99% | 0.55% |
| Feb. 20, 2024 | Levisetti Matteo | Chief Medical Officer | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 45,754,794 | 9999.99% | 0.05% |
| Jan. 2, 2024 | Kiener Peter A | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 45,754,794 | 9999.99% | 0.05% |
| Jan. 2, 2024 | DRISCOLL FREDERICK W | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 45,754,794 | 9999.99% | 0.05% |
| Jan. 2, 2024 | Garzone Pamela | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 45,754,794 | 9999.99% | 0.05% |
| Jan. 2, 2024 | Verheyen Patrick | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 45,754,794 | 9999.99% | 0.05% |
| Jan. 2, 2024 | Morich Frank | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 45,754,794 | 9999.99% | 0.05% |